Nav: Home

New soft material could reduce complications for women suffering from urinary incontinence

March 16, 2016

  • Between 3 and 6 million people in the UK suffer some degree of urinary incontinence

  • The NHS carries out 13,500 operations each year to treat urinary incontinence, with 15% of women suffering serious complications as a result

  • The researcher at Sheffield have developed a softer, elastic material to be used in surgery which replicates the natural recoil of the pelvic floor

Researchers at the University of Sheffield have developed a novel implantable material which could reduce the number of debilitating side-effects that occur as a result of using a material that is too rigid for surgical treatment of incontinence.

In the UK, it is estimated between 3 and 6 million people suffer with some degree of urinary incontinence. Stress urinary incontinence is the leakage of urine when there is pressure on the bladder, such as through sneezing, laughing or exercise, often as a result of childbirth, surgery or menopause.

The research at Sheffield, with two separate papers published in PLOS ONE and the Journal of Urology, provides evidence for using a softer and more elastic material to support the urethra. This comes as a new study shows that the long-term impact of vaginal childbirth delivery is associated with an almost twofold increase in the risk of stress urinary incontinence.

Current treatment for the condition uses a rigid woven polypropylene mesh device, implanted under the urethra to repair damaged or weakened tissue. The material used in this device was originally designed for hernia repairs but was rapidly repurposed in the mid-1990's for use in urinary incontinence surgery, for which it is now used worldwide.

The majority of women with the condition elect to undergo surgery, with the NHS carrying out around 13,500 operations each year in the UK to treat urinary incontinence or pelvic organ prolapse. However, over the last decade, thousands of patients have developed complications from the use of the current material after stress urinary incontinence surgery. Serious complications, including chronic pain, infection, failure or erosion of the implant are estimated to occur in around 15 per cent of women.

Sheffield's Centre for Biomaterials and Tissue Engineering Group, working with international collaborators in Europe, have constructed a novel implantable device using elastic polyurethane which replicates the natural recoil of a healthy pelvic floor.

Professor Sheila MacNeil, Department of Materials Science and Engineering at Sheffield, who is leading the research, said: "In younger women, the organs of the pelvis have a strong and elastic pelvic floor, supported by a combination of connective tissue, muscles and ligaments that provide 'a well-sprung floor', much like a trampoline.

"Unfortunately, one of the consequences of pregnancy is that there is often damage and weakening to the tissues of the pelvic floor, as it becomes further stretched, with a resulting loss of elasticity."

"After 6 years of product development and pre-clinical testing, the elastic polyurethane material we have rigorously tested is neither too strong nor too brittle, it does not weaken over time and aims to avoid the complications that currently occur with using polypropylene mesh.

The team have implanted the device in physiologically relevant animal models through a European collaboration with colleague Professor Jan Deprest in Leuven. This is an important aspect of pre-clinical assessment to ensure that the implanted material is compatible. This demonstrates that their device becomes well integrated into tissues and is associated with much less of an inflammatory response than the current polypropylene mesh used.

The research at Sheffield could mark the beginning of a clinical testing phase of this new device, to end the pain and misery for thousands of patients worldwide.
The research was funded by grants from the European Union, The Marie Curie Network, The Urology Foundation, The Robert Luff Foundation and The Rosetrees Trust. @SheffUniEng

University of Sheffield - Faculty of Engineering

Related Incontinence Articles:

Mixed results on effectiveness of acupuncture to treat stress urinary incontinence, infertility
Electroacupuncture improved stress urinary incontinence -- that's when a woman can experience an involuntary loss of urine such as when sneezing or coughing -- but acupuncture did not increase the likelihood of childbirth among women with infertility, according to two studies published by JAMA.
New genomic analysis promises benefit in female urinary incontinence
Urinary incontinence in women is common, with almost 50 percent of adult women experiencing leakage at least occasionally.
Majority of incontinence treatments deliver poor results
Surgery is the most reliable method of treatment for incontinence -- curing the condition in just over eight in ten cases; other types of treatment, meanwhile, do not deliver the same kind of success.
Body composition may affect older women's risk of urinary incontinence
In a study of older women, the prevalence of stress- and urgency urinary incontinence (SUI and UUI) was at least two-fold higher among women in the highest category of body mass index (BMI) or fat mass compared with women in the lowest category.
ATOMS device effectively treats male incontinence with high patient satisfaction
In the largest study yet to assess the long-term safety and efficacy of the adjustable transobturator male system (ATOMS) to treat incontinence in men following invasive prostate treatment, the overall success and dry rates were 90% and 64%, respectively, after a median of 31 months.
Stress urinary incontinence drug's benefits do not outweigh harms
A new study indicates that the benefits of duloxetine, a drug used in Europe to treat stress incontinence in women, do not outweigh the harms.
Weethinking the role of bacteria in incontinence
We have much to learn about the bladder, bacteria in the urinary tract, and their relationship to incontinence.
Botox may beat neural stimulation for urge incontinence, but has risks
A head-to-head comparison of sacral neuromodulation and botulinum toxin led by a Duke Health researcher shows that Botox provides more daily relief for women suffering from urgency urinary incontinence, but might also be associated with more adverse events.
Mayo clinic first to implant device to solve fecal incontinence
JACKSONVILLE, Fla. -- A clinical team on Mayo Clinic's Florida campus is the first to offer four patients with long-term fecal incontinence a new and potentially long-lasting treatment -- a small band of interlinked magnetic titanium beads on a titanium string that successfully mimics the function of the anal sphincter.
New soft material could reduce complications for women suffering from urinary incontinence
Researchers at the University of Sheffield have developed a novel implantable material which could reduce the number of debilitating side-effects that occur as a result of using a material that is too rigid for surgical treatment of incontinence.

Related Incontinence Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".